Navigation Links
Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
Date:11/21/2007

SOUTH SAN FRANCISCO, Calif., Nov. 21 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) announced today that George A. Scangos, Ph.D., the company's president and chief executive officer will present at the 19th Annual Piper Jaffray Health Care Conference at 3:00 p.m. ET / 12:00 p.m. PT on Tuesday, November 27, 2007.

The presentation will be webcast and may be accessed in the Event Calendar page under Investors on the Exelixis website at http://www.exelixis.com.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development for cancer and renal disease. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ ...ced today that Barry D. Quart, Pharm.D., president...Piper Jaffray 21st Annual Health Care Conference. ...ffray 21st Annual Health Care Conference,Date: ...astern Time,Location: The New York Palace Hotel, ...
(Date:11/24/2009)... Ambassador to also Visit Detr..., 2009 -- , , ,Who: David Appia, French Ambassador...O of the Invest in France Agency, , , , ,What: Am...discuss recent pro-business initiatives adopted by...nd academic landscape for innovation and developme...
(Date:11/24/2009)... , CALGARY and BLENHEIM, Ontario, Nov. 24 /PRN...unced today it is acquiring the assets of Hyland S... Ontario. The addition of Hyland Seeds will furthe...as the company anticipates the introduction of Sm...icide Tolerant Trait Technology in corn in 2012. T...
(Date:11/24/2009)... Health care employment grew...the only one to show consistent growth during the ...pitals remain in trouble, and health systems are c...sonnel, instead of just administrators. , ...th care employment continued growing in October de...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...ologies, Inc. (Nasdaq: EMIS ), a biopharmaceutica...livery of therapeutic molecules using its,eligen(R...t its,presentation at the BIO CEO & Investor Confe...ers should go to the Investor Relations page of th...ir.asp at 2:45 PM to hear,the live presentation. ...
...uromag(R),the world-leading equipment for non-inva...cephalography (MEG) technology, has been ordered b...http://www.newscom.com/cgi-bin/prnh/20020318/ELEKT...ation and extraordinary patient,care, The Nebraska...es,Hospital of Distinction award for three consecu...
...ntly clean and help heal ... Medical, LLC, today,announced that it has launche...nces the use of low-frequency cavitational ultraso...t-effective alternative to painful sharps,debridem...nd Therapy System,assists healing by gently removi...
Other Biology Technology:Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12 2Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center 2Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center 3Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM) 2Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM) 3
(Date:11/24/2009)... keep weakened and flabby arteries from collapsing... those stents are no longer needed -- once the art...reviously, doctors had no choice but to leave them...University,s Department of Biomedical Engineering ...that carries drugs where they,re needed, then diss...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife ...t revealing that the last remaining population of ...due to the rising tide of poaching and habitat los...nform Russian officials of what needs to be done t...gest cat. , The report was released...
(Date:11/24/2009)...Md. (November 24, 2009) New research on bacterial...systems reveals predictable temporal patterns, sug...s as markers for monitoring climate change in the ...he Proceedings of the National Academy of Science... in the six rivers shifted synchronously over time...
Breaking Biology News(10 mins):A coating for life 2Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients 4590 1UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients 4590 2UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients 4590 3FluoroPharma to Present Phase I Study Results of Novel Positron Emission Tomography 28PET 29 Myocardial Perfusion Imaging 28MPI 29 Tracer 48848 1FluoroPharma to Present Phase I Study Results of Novel Positron Emission Tomography 28PET 29 Myocardial Perfusion Imaging 28MPI 29 Tracer 48848 2Howard Leight Selects Tiziani Whitmyre for Public Relations Services 48845 1Howard Leight Selects Tiziani Whitmyre for Public Relations Services 48845 2
...king to improve on nature, scientists used a spice...synthetic molecules that, in lab settings, are abl...eading. , The researchers are combining organic c...ogy techniques in developing and testing pharmaceu... cancer cells. The synthetic molecules are derived...
... analysis of its kind to date for bipolar disorder...of sodium and calcium in brain cells. Researchers ...tal Health, part of the National Institutes of Hea... variation in two genes that make components of ch...nd out of cells, including neurons. , "A neuron,...
...nic hydrogels developed by Carnegie Mellon Univers... to enable bone regeneration. The hydrogels, creat... Jeffrey Hollinger, have proven to encourage the g...rowth and development of bone. Doctoral student Si...ug. 17 at the 236th national meeting of the Americ...
Other Biology News:Synthetic moleculues could add spice to fight against cancer 2Synthetic moleculues could add spice to fight against cancer 3Largest study of its kind implicates gene abnormalities in bipolar disorder 2Hydrogels provide scaffolding for growth of bone cells 2
12(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
Biology Products: